About

Nelson Sun has served as Aardvark's Chief Financial Officer since June 2019 and additionally as Chief Operating Officer since February 2026. He has more than 20 years of experience in financial management, business operations and corporate strategy, with leadership roles at private equity firms. Before joining Aardvark he was an Operating Partner at Dubilier & Company from 2011 to 2019 and a Vice President at Valor Equity Partners from 2005 to 2011, where he worked on mergers and acquisitions, portfolio management and operational oversight of portfolio companies. Mr. Sun received his M.B.A. in Finance from The Wharton School, an M.A. in International Studies from the University of Pennsylvania, and a B.A. from the University of California, San Diego.

Roles

Aardvark Therapeutics, Inc.
Chief Financial Officer & Chief Operating Officer · Current role
June 2019–present
Aardvark Therapeutics, Inc.
Chief Financial Officer
2019 - present
Aardvark Therapeutics, Inc.
Chief Operating Officer
February 2026 - present
Dubilier & Company
Operating Partner
2011 - 2019
Valor Equity Partners
Vice President
2005 - 2011

Fixed Compensation

FY 2025
Salary
$432,654
ComponentAnnual base salary earned in 2025
Total compensation
$2,547,946

Performance Compensation

Data from FY 2025

Cash incentive

Non-equity incentive plan compensation
$170,646
Target Opportunity
PlanAnnual performance-based cash bonus

Stock awards

Option awards
$1,944,646
FormStock options, ASC 718 grant-date fair value

Also at Aardvark Therapeutics, Inc.

Related

See how VectorShift works for your firm

Request Demo